Akebia Therapeutics (AKBA) Cash Flow: Operating & Free Cash Flow

Akebia Therapeutics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Akebia Therapeutics, Inc. (AKBA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	-5.35	-69.41	-51.93	-94.23	-282.02	-383.46	-279.66	-143.59	-76.91
Depreciation & Amortization	1.27	37.50	37.63	37.70	37.97	33.59	38.65	2.42	0.62
Deferred Income Tax	0.00	0.00	0.00	0.00	0.00	204.08	-6.63	-28.34	0.00
Stock Based Compensation	11.28	7.78	9.32	17.85	22.74	24.46	11.93	19.04	8.87
Change in Working Capital	16.47	-39.68	-20.73	-1.44	-105.61	-13.67	-99.07	36.02	7.25
Change in Accounts Receivable	-14.14	4.05	0.99	11.30	-24.03	12.01	-22.20	33.38	-0.39
Change in Inventory	-23.13	-28.40	-2.54	19.09	-24.95	6.16	-29.14	0.03	16.79
Change in Accounts Payable	3.08	-1.36	-5.24	1.50	-11.74	3.68	1.37	13.72	4.96
Change in Other Working Capital	37.40	-1.18	-0.18	0.02	37.96	-35.52	-49.10	-11.11	-14.11
Other Operating Activities	37.40	23.15	2.32	-33.03	37.96	24.61	77.35	16.95	4.02
Net Cash from Operating Activities	67.99	-40.66	-23.38	-73.15	-252.97	-110.39	-257.44	-97.49	-56.16
Investing Activities
Capital Expenditures	-8.10	-0.03	0.00	-0.11	-0.06	-0.32	-6.66	-1.61	-1.62
Acquisitions	0.00	0.00	0.00	0.00	0.00	39.69	0.00	6.15	1.62
Purchases of Investments	0.00	0.00	0.00	0.00	0.00	-99.93	0.00	-224.22	-330.64
Sales/Maturities of Investments	0.00	0.00	0.00	0.00	40.00	60.25	217.83	256.27	155.00
Other Investing Activities	-7.93	0.00	0.00	0.00	0.00	-39.69	0.00	32.05	-1.62
Net Cash from Investing Activities	-7.93	-0.03	0.00	-0.11	39.94	-40.00	211.18	36.59	-177.26
Financing Activities
Debt Repayment	-0.46	-37.10	-32.00	-33.00	0.00	19.98	62.67	-0.02	0.00
Common Stock Issued	66.68	43.03	6.79	7.60	88.95	210.52	26.17	95.93	114.93
Common Stock Repurchased	0.00	-1.27	0.00	0.00	0.00	0.00	-0.43	0.00	0.00
Other Financing Activities	-4.97	-1.27	0.00	40.00	44.78	1.23	0.56	0.65	1.31
Net Cash from Financing Activities	72.93	49.66	-25.21	14.60	133.73	231.72	88.97	96.56	116.24
Summary
Net Change in Cash	132.99	8.97	-48.59	-58.67	-79.29	81.33	42.71	35.66	-117.18
Cash at Beginning of Period	53.55	44.58	93.17	151.84	231.13	149.80	107.10	71.44	187.34
Cash at End of Period	186.54	53.55	44.58	93.17	151.84	231.13	149.80	107.10	70.16
Free Cash Flow	59.89	-40.69	-23.38	-73.27	-253.02	-110.71	-264.10	-99.10	-57.78
Supplemental Disclosures
Interest Paid	-	5.04	6.06	6.76	9.63	7.84	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Akebia Therapeutics Cash Flow

What is Akebia Therapeutics's free cash flow?

Akebia Therapeutics generated free cash flow of $59.89M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $67.99M minus $8.10M of capital expenditures. Free cash flow equaled 25.4% of revenue.

How much does Akebia Therapeutics spend on capital expenditures?

Akebia Therapeutics spent $8.10M on capital expenditures in fiscal 2025, compared with $33.00K a year earlier. That equals 11.9% of operating cash flow.

Does Akebia Therapeutics pay dividends or buy back shares?

Akebia Therapeutics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition